NUR 540 Module 2 Short Paper Example

Ten Minutes After a Cookie: The Pathophysiology of Peanut Anaphylaxis in a School-Age Child

[Student Name]

Southern New Hampshire University

NUR 540: Advanced Pathophysiology Across the Life Span

Short Paper

[Instructor Name]

[Date]

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

Ten Minutes After a Cookie: The Pathophysiology of Peanut Anaphylaxis in a School-Age Child

Anaphylaxis is an acute, potentially life-threatening systemic allergic reaction whose signs can involve the skin, airway, gut and circulation at once (Shaker et al., 2020). In children, food is the most common trigger, and the reaction can move from a single hive to shock in minutes. This paper explains the immunologic and inflammatory mechanisms behind a composite case of peanut anaphylaxis in an 8-year-old. It argues that every sign in the case can be traced to a handful of mast cell mediators acting on blood vessels and smooth muscle, and that epinephrine is first-line treatment because it is the only drug that opposes all of those actions at once.

The Case

An 8-year-old weighing 26 kg, with peanut allergy diagnosed at age three, ate part of a classmate's cookie at lunch. Within ten minutes the child had widespread hives, swelling of the lips, a hoarse cough, audible wheezing, abdominal cramps and vomiting. The school nurse found a heart rate of 142 beats per minute, blood pressure of 78/42 mm Hg and oxygen saturation of 91% on room air. The nurse gave a 0.3 mg epinephrine auto-injector into the outer thigh and called emergency services. Within five minutes the wheezing eased and the blood pressure rose to 96/58. In the emergency department the child received oxygen and fluids and was observed; symptoms fully resolved, and the child was discharged the next morning with two auto-injectors and an allergist referral.

Sensitization: The Reaction Before the Reaction

Anaphylaxis to peanut is a type I, or immediate, hypersensitivity reaction, and it depends on an earlier exposure that produced no symptoms. At that first exposure, peanut proteins were taken up by antigen-presenting cells and presented to helper T cells that responded with a type 2 pattern, releasing cytokines such as interleukin-4 and interleukin-13. These signals drove B cells to switch to producing immunoglobulin E (IgE) specific to peanut proteins. The IgE then bound to high-affinity receptors on mast cells in the skin, airways and gut, and on basophils in the blood, and it stays attached for long periods (Rogers, 2023). The child was therefore carrying armed cells long before the cookie.

Degranulation and the Mediators

When the child ate peanut again, its proteins bound to IgE on neighboring receptors and cross-linked them, triggering mast cells and basophils to release preformed granules within seconds and to synthesize new mediators within minutes. Table 1 links the main mediators to the signs in the case.

Table 1

Mast Cell Mediators and the Signs They Produce

The circulation deteriorated for two reasons. Widespread vasodilation lowered systemic vascular resistance, and increased capillary permeability let plasma leak into tissues, visible as swelling of the lips and invisible throughout the body. Venous return fell, so cardiac output fell, and the heart rate rose to compensate. For an 8-year-old, a systolic pressure of 78 mm Hg is below the lower limit usually accepted for that age, so this was shock, not simply a fast pulse. In the airways, bronchoconstriction, mucosal swelling and mucus narrowed the lumen, producing wheeze and an oxygen saturation of 91%, while the hoarse cough suggested swelling near the larynx. Gut smooth muscle contraction explained the cramps and vomiting.

The case also meets the clinical criteria for anaphylaxis described by an international symposium: skin or mucosal signs appearing within minutes to hours, joined by trouble breathing or a drop in blood pressure, after contact with a probable allergen (Sampson et al., 2006).

Why Epinephrine Works and Antihistamines Do Not

Epinephrine is the first-line drug for anaphylaxis (Shaker et al., 2020) because it acts on several adrenergic receptors that together oppose the mediators. Through alpha-1 receptors it constricts blood vessels, raising blood pressure and reducing mucosal swelling in the airway. Through beta-1 receptors it strengthens and quickens the heartbeat. Through beta-2 receptors it relaxes bronchial smooth muscle and reduces further mediator release from mast cells. Given into the outer thigh muscle, it is absorbed quickly, which is why the child's wheeze and blood pressure improved within minutes.

An antihistamine blocks only one mediator at one receptor type. It can ease itching and hives, but it does nothing against leukotrienes, prostaglandins or platelet-activating factor, and it acts too slowly to reverse airway obstruction or shock. Giving an antihistamine first, and waiting to see whether it works, is a well-known source of delayed epinephrine.

Observation and the Biphasic Reaction

Some patients have a biphasic reaction, a return of symptoms hours after the first reaction has resolved, without new exposure. The mechanism is not fully understood but is thought to involve continued release of newly synthesized mediators and recruitment of other inflammatory cells. Severe initial reactions and the need for more than one dose of epinephrine are risk factors, and antihistamines and glucocorticoids are not reliable ways to prevent a second phase (Shaker et al., 2020). This child's reaction was severe, with shock, which is why the emergency team kept the child overnight rather than discharging after a few hours.

Age and This Patient

Age shapes anaphylaxis in several ways. In young children, food allergy is the most common cause, and respiratory signs such as cough and wheeze are prominent, whereas in older adults medications and insect stings are more common triggers and cardiovascular collapse is a greater danger. Recognizing shock in a child requires age-specific blood pressure limits, since compensation through a fast heart rate can hide falling perfusion until late. School-age children also depend on adults to recognize the reaction and give epinephrine, so prevention involves the school: a written emergency plan, staff trained to use auto-injectors and devices stored where the child spends the day. Dosing is weight-based, and at 26 kg this child had just reached the weight at which the 0.3 mg device is commonly used.

Conclusion

This child's reaction began months before the cookie, when sensitization armed mast cells with peanut-specific IgE. Cross-linking released histamine, leukotrienes, prostaglandins and platelet-activating factor, which dilated vessels, opened capillaries, narrowed airways and contracted the gut, producing every sign the school nurse saw. Epinephrine reversed the reaction because it opposes those actions through alpha and beta receptors at once, and observation guarded against a second phase. The mechanisms are the same at any age, but in a child, recognition and treatment depend on the adults nearby.

References

Rogers, J. L. (Ed.). (2023). McCance & Huether's pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier.

Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., Brown, S. G., Camargo, C. A., Cydulka, R., Galli, S. J., Gidudu, J., Gruchalla, R. S., Harlor, A. D., Hepner, D. L., Lewis, L. M., Lieberman, P. L., Metcalfe, D. D., O'Connor, R., Muraro, A., . . . Decker, W. W. (2006). Second symposium on the definition and management of anaphylaxis: Summary report. Journal of Allergy and Clinical Immunology, 117(2), 391-397. https://doi.org/10.1016/j.jaci.2005.12.1303

Shaker, M. S., Wallace, D. V., Golden, D. B. K., Oppenheimer, J., Bernstein, J. A., Campbell, R. L., Dinakar, C., Ellis, A., Greenhawt, M., Khan, D. A., Lang, D. M., Lang, E. S., Lieberman, J. A., Portnoy, J., Rank, M. A., Stukus, D. R., & Wang, J. (2020). Anaphylaxis: A 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. Journal of Allergy and Clinical Immunology, 145(4), 1082-1123. https://doi.org/10.1016/j.jaci.2020.01.017